Astellas Pharma, Inc. (ALPMY)
16.19
-0.01
(-0.06%)
USD |
OTCM |
Feb 19, 16:00
Astellas Pharma Price : 16.19 for Feb. 19, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Nxera Pharma Co., Ltd. | 5.44 |
| PeptiDream Inc. | 9.27 |
| Stemcell Holdings, Inc. | 0.06 |
| Healios KK | 2.10 |
| AnGes, Inc. | 0.3602 |
Price Related Metrics
| PE Ratio | 13.51 |
| PS Ratio | 2.111 |
| Price to Book Value | 2.578 |
| Price to Free Cash Flow | 11.22 |
| Earnings Yield | 7.40% |
| Market Cap | 29.00B |
| Operating PE Ratio | 10.75 |
| Normalized PE Ratio | 13.51 |